Full Breakdown
Families Seek Redress Over Sodium Valproate Harm
8/13/2026, 4:23:17 AM
Core Event
Families of children affected by sodium valproate are pressing the UK government for compensation and a clear care pathway. Six years after the 2020 Cumberlege Report highlighted these risks, families remain without a substantive response. Dr Henrietta Hughes, England’s first patient-safety commissioner, wrote to Prime Minister Sir Keir Starmer and set a 16 July deadline for a reply, which she has not received.
Background & Context
The Cumberlege Report, published in 2020, documented that sodium valproate—used to treat epilepsy and bipolar disorder—poses a high risk of birth defects when taken by pregnant women. The report called for a national redress scheme and long-term support for affected children. Susan says she only felt “closure” after the report’s publication, but the promised systemic changes have not materialised.
Official Statements & Responses
The UK government told the BBC it will respond to the recommendations in the Cumberlege Report and to Dr Hughes’s letter “in due course.” No detailed plan or timeline has been provided, and the government has not addressed the specific concerns raised by families about housing, medical care, and ongoing support for their children.
Verbatim Quotes
- “I'm angry. Parents are not getting any younger and we need to set out a care path for our children. It needs to be sorted quickly,” — Susan
What’s Next
Families continue to await a formal government response to the 16 July deadline. Without a stated timetable, they fear further delays in establishing the care pathways and financial redress they deem essential for their children’s lifelong needs.
